The management of severe primary graft failure after cardiac transplantation.
Hauer
Daniela
D
Department of Anesthesiology, University Hospital Grosshadern, Ludwig-Maximilians University, Munich, Germany.
Beiras-Fernandez
Andres
A
Kur
Felix
F
Weis
Marion
M
Schmoeckel
Michael
M
Weis
Florian C
FC
D002311:Cardiomyopathy, Dilated / Q000601:surgery; D002315:Cardiopulmonary Bypass; D015199:Extracorporeal Membrane Oxygenation; D006085:Graft Survival; D016027:Heart Transplantation / Q000009:adverse effects* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D017211:Treatment Failure; D014665:Vasodilator Agents / Q000627:therapeutic use*
D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan